These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2577984)

  • 1. Scleroglucan sustained-release oral preparations. Part I. In vitro experiments.
    Touitou E; Alhaique F; Riccieri FM; Riccioni G; Santucci E
    Drug Des Deliv; 1989 Dec; 5(2):141-8. PubMed ID: 2577984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scleroglucan sustained release oral preparations. Part II. Effects of additives.
    Alhaique F; Beltrami E; Riccieri FM; Santucci E; Touitou E
    Drug Des Deliv; 1990 Mar; 5(3):249-57. PubMed ID: 1670505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two galactomannans and scleroglucan as matrices for drug delivery: preparation and release studies.
    Coviello T; Alhaique F; Dorigo A; Matricardi P; Grassi M
    Eur J Pharm Biopharm; 2007 May; 66(2):200-9. PubMed ID: 17156985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new scleroglucan/borax hydrogel: swelling and drug release studies.
    Coviello T; Grassi M; Palleschi A; Bocchinfuso G; Coluzzi G; Banishoeib F; Alhaique F
    Int J Pharm; 2005 Jan; 289(1-2):97-107. PubMed ID: 15652203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and release of dihydralazine sulphate from tabletted microcapsules.
    Oner L; Yalabik-Kaş HS; Hincal AA
    J Microencapsul; 1984; 1(2):123-30. PubMed ID: 6336521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prolongation of theophylline derivative release with cellulose acetate based tablets].
    Guyonnet T; Brossard C; Lefort des Ylouses D
    J Pharm Belg; 1990; 45(2):111-9. PubMed ID: 2355304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thermoplastic granulation as an alternative method for the preparation of hydrophilic-lipophilic oral matriix tablets].
    Dvorácková K; Rabisková M; Masteiková R; Vocilková L
    Ceska Slov Farm; 2007 Jun; 56(3):129-34. PubMed ID: 17867525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Manufacture and in vitro characterization of a new fluid theophylline sustained-release form. Sachets with microcapsules for administration in a drinkable sustained-release suspension].
    Weiss G; Klemm FH; Fuchs WS; Stanislaus F; Zema M; Calanchi M
    Arzneimittelforschung; 1998 May; 48(5A):604-12. PubMed ID: 9676353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A; Ozkan Y; Işimer A
    Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and evaluation of a controlled-release theophylline tablet. Preliminary communication.
    Gai MN; Pezoa R; Corbeaux J; Arancibia A
    Farmaco; 1989 Nov; 44(11):1119-26. PubMed ID: 2701966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation of preoral sustained-release preparations with a base of biodegradable polymers. 3. Preparation of matrix tablets with a base of poly-3-hydroxybutyric acid].
    Mank R; Kala H; Richter M; Babel W; Sattler K
    Pharmazie; 1989 Aug; 44(8):545-7. PubMed ID: 2594825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
    Brouillet F; Bataille B; Cartilier L
    Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug delivery matrices based on scleroglucan/alginate/borax gels.
    Matricardi P; Onorati I; Coviello T; Alhaique F
    Int J Pharm; 2006 Jun; 316(1-2):21-8. PubMed ID: 16554128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Release, absorption and elimination of theophylline from fast and slowly released oral formulations].
    Frömming KH; Schwabe L; Staib AH; Rietbrock N; Lassmann A; Molz KH; Schuppan D; Siebert-Weigel M; Voegele D
    Arzneimittelforschung; 1983; 33(3):446-52. PubMed ID: 6683521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation of sustained - release lithium carbonate matrix tablets: influence of hydrophilic materials on the release rate and in vitro-in vivo evaluation.
    Emami J; Tavakoli N; Movahedian A
    J Pharm Pharm Sci; 2004 Nov; 7(3):338-44. PubMed ID: 15576014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Per-oral controlled release dosage form of theophylline using soybean protein.
    Machida Y; Tokumura T; Nagai T
    Drug Des Deliv; 1987 Feb; 1(3):187-92. PubMed ID: 3509332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release of theophylline from inert matrices: effect of channeling material on release rate.
    Ghaly ES; Malavé MI; Rivera WJ; Martí A
    P R Health Sci J; 1993 Dec; 12(4):255-8. PubMed ID: 8140202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms.
    Goole J; Vanderbist F; Amighi K
    Int J Pharm; 2007 Apr; 334(1-2):35-41. PubMed ID: 17097841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.